Table 2.

Percentage of CXCR-4 expression on CD34+ cells


Patient ID

Percent of CXCR-4 on CD34+
Engrafters  
   9   2.2  
   29*  4.1  
   26*  19.1  
   8   21.5  
   27   22.2  
   28   24.5  
   10   63.3  
   24*  80.4  
   5   95.3  
   20*  96.1  
   14   98.9  
   Mean ± SD   48.0 ± 39.0  
Nonengrafters  
   41   4.1  
   45*  8.4  
   34*  22.5  
   35   34.9  
   42   54.2  
   47   65  
   44   69.5  
   46*  75.9  
   43   73.4  
   39*  98.5  
   Mean ± SD
 
50.6 ± 9.4
 

Patient ID

Percent of CXCR-4 on CD34+
Engrafters  
   9   2.2  
   29*  4.1  
   26*  19.1  
   8   21.5  
   27   22.2  
   28   24.5  
   10   63.3  
   24*  80.4  
   5   95.3  
   20*  96.1  
   14   98.9  
   Mean ± SD   48.0 ± 39.0  
Nonengrafters  
   41   4.1  
   45*  8.4  
   34*  22.5  
   35   34.9  
   42   54.2  
   47   65  
   44   69.5  
   46*  75.9  
   43   73.4  
   39*  98.5  
   Mean ± SD
 
50.6 ± 9.4
 

AML cells from 21 different patients were labeled with antibodies to CD34 and CXCR-4. CXCR-4 expression is displayed as a percentage of CD34+ cells. There did not seem to be a difference in CXCR-4 expression levels between AML cases capable of NOD/SCID engraftment and those not able to do so. Of note, the highest CXCR-4 expression was observed in a nonengrafter and the lowest was seen in an engrafting AML sample.

*

Samples tested for intracellular calcium release from CD34+ cells when stimulated with 100 ng/mL SDF-1 as described in “Calcium flux measurement.” Student paired t test: 1.0

or Create an Account

Close Modal
Close Modal